Health & Safety Industry Today

Central Pontine Myelinolysis Market to Demonstrate Progress at a ~5.5% of CAGR by 2023

In the coming years, it is expected that the Global Central Pontine Myelinolysis Market will advance with higher growth rate as compared to previous years. Rising pressure to curb healthcare costs has fuelled the growth of the market for Central Pontine Myelinolysis Market.
Published 25 January 2018 adds “Central Pontine Myelinolysis Market -2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

The report titled “Central Pontine Myelinolysis Market -Forecast to 2023″ is a direct appreciation by Market Research Future of the market potential of the Central Pontine Myelinolysis Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market! The global CPM market is expected to reach US$ 2.2 billion by 2023, and the market is projected to grow at a CAGR of ~ 5.5% during the forecast period 2017-2023. 

Regional Analysis of Global Central Pontine Myelinolysis Market:
The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care driven by the increasing incidence of related diseases and clinical conditions that can cause CPM. Additionally, the fastest uptake of new drugs in the US drives the central pontine myelinolysis market. Also, concentration of major research companies and hospitals in the developed countries of this region is adding fuel to the market growth. The large expenditure on the US healthcare, accounting to 16% of GDP, also cruises the sale of central pontine myelinolysis treatment.

Europe is the second largest market in the world due to high income and healthcare penetration. Europe is led by nations such as Germany and France. UK is expected to be the fastest growing market.

Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

The report for Global Central Pontine Myelinolysis market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Major Players in the Central Pontine Myelinolysis Market:
Some of key players profiled in the report are Fujifilm Holdings Corporation, GE Healthcare, Siemens Healthcare GmbH, Philips Healthcare (Koninklijke Philips N.V.), Shimadzu Corporation, Toshiba Medical Systems Corporation, Carestream Health, Hitachi Medical Corporation and others.

Market Scenario of the Central Pontine Myelinolysis Market:
Central Pontine Myelinolysis (CPM), also known as osmotic demyelination syndrome or central pontine demyelination, is a neurological disorder caused by severe damage of the myelin sheath of neurons. CPM mostly affects the pons area of the brain and is characterized by acute paralysis, difficulty swallowing (dysphagia), difficulty speaking (dysarthria), and other neurological symptoms. These neurological symptoms are manifested into nausea and vomiting, disturbed consciousness, gait changes, confusion, headache, seizures etc. Serious progressive neurological symptoms are the progressive development of spastic tetraparesis, pseudobulbar palsy etc.

The causes of CPM are, rapid correction of low blood sodium levels (hyponatremia) affected by severe liver disease, liver transplant, alcoholism, severe burns, malnutrition, anorexia, severe electrolyte disorders, AIDS, hyperemesis gravidarum, anorexia nervosa, hematopoietic stem cell transplantation, Wernicke encephalopathy etc. The market drivers for central pontine myelinolysis market are increase in the risk factors such as hyponatremia cases, increasing screening and penetration of healthcare, growing income and healthcare expenditure etc. The market restraints are poor cure rates of central pontine myelinolysis, treatment, high cost of treatment etc.


Segmentation of Global Central Pontine Myelinolysis Market:
The global central pontine myelinolysis market has been segmented on the basis of diagnosis, treatment, and end users.

Based on diagnosis, the market has been segmented as magnetic resonance imaging (MRI), computerized tomography (CT), electroencephalography and others.

Based on treatment, the market has been segmented as vitamin supplementation, electrolyte mainainence and others.

Based on the end users, the market has been segmented as hospitals & clinics, academic and research and others.

Major TOC of Central Pontine Myelinolysis Market:
Chapter 1. Introduction

Chapter 2. Research Methodology

Chapter 3. Market Dynamics

Chapter 4. Market Factor Analysis

Chapter 5. Global Central Pontine Myelinolysis Market, By Diagnosis

Chapter 6. Global Central Pontine Myelinolysis Market, By Treatment

Chapter 7. Global Central Pontine Myelinolysis Market, By End Users

Chapter 8. Global Central Pontine Myelinolysis Market, By Region

Chapter 9. Competitive Landscape

Chapter 10. Company Profile

Chapter 11. Conclusion

Chapter 12. Appendix



About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, 
Pune – 411028
Maharashtra, India
+1 646 845 9312

Other Industry News

Ready to start publishing

Sign Up today!